Tamoxifen and other estrogen receptor modulators are used both as adjuvant therapy for estrogen receptor / progesterone receptor (ER/PR) positive breast cancer and as a risk reduction strategy in women at increased risk of breast cancer. Here, PGR is linked to breast cancer.